Pharmaceuticals

Pharmaceuticals

This Covid-19 vaccine is still in trials, but an Indian firm is already producing it
Serum, the Indian drug maker, is putting its faith in a Covid-19 vaccine being developed at the University of Oxford by starting mass production before it has been declared ready for use. It is a calculated risk backed by the deep pockets behind the world’s largest vaccine maker. Chairman Cyrus Poonawalla has a net worth of $10.6 billion and is known as India’s “vaccine king.” His company hopes to produce 40 million doses of the vaccine by September, the same deadline by which Oxford is aiming to complete human trials of the ChAdOX1 vaccine. About 1,100 people in Britain will be injected with the vaccine, as part of a trial funded by the British government that was started after promising re
Why China’s cancer patients have great sympathy for convicted ‘drug god’
Zhai Yiping clearly broke the law. But is what he did wrong? The question has been raised as part of a discussion of China’s health care system after Zhai was punished for selling foreign drugs to cancer patients in a country where those medications are unavailable or expensive. After being diagnosed with liver cancer in 2014, Zhai devoured news of the latest cancer drugs released around the world. In 2016, he found two new overseas medicines that were more effective than similar medications in China and cost less.  Zhai spread the news to other patients in China and, eventually, the demand became so high that he started to smuggle these drugs from Germany. He charged a 5% markup. He would b